These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19185065)

  • 1. Identification of regulatory T cells in systemic lupus erythematosus.
    Gerli R; Nocentini G; Alunno A; Bocci EB; Bianchini R; Bistoni O; Riccardi C
    Autoimmun Rev; 2009 Mar; 8(5):426-30. PubMed ID: 19185065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
    Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
    Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
    Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
    Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH; Anderson M; Le E; La Cava A
    Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25+ T cells in normal skin and inflammatory dermatoses.
    de Boer OJ; van der Loos CM; Teeling P; van der Wal AC; Teunissen MB
    J Histochem Cytochem; 2007 Sep; 55(9):891-8. PubMed ID: 17478450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.
    Franz B; Fritzsching B; Riehl A; Oberle N; Klemke CD; Sykora J; Quick S; Stumpf C; Hartmann M; Enk A; Ruzicka T; Krammer PH; Suri-Payer E; Kuhn A
    Arthritis Rheum; 2007 Jun; 56(6):1910-20. PubMed ID: 17530636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
    Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
    Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
    Xing Q; Su H; Cui J; Wang B
    Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
    Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance.
    Vargas-Rojas MI; Crispín JC; Richaud-Patin Y; Alcocer-Varela J
    Lupus; 2008 Apr; 17(4):289-94. PubMed ID: 18413409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells.
    Scheinecker C; Bonelli M; Smolen JS
    J Autoimmun; 2010 Nov; 35(3):269-75. PubMed ID: 20638240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
    Sharabi A; Lapter S; Mozes E
    J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.
    Barath S; Aleksza M; Tarr T; Sipka S; Szegedi G; Kiss E
    Lupus; 2007; 16(7):489-96. PubMed ID: 17670847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
    Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.
    Shimizu J; Yamazaki S; Takahashi T; Ishida Y; Sakaguchi S
    Nat Immunol; 2002 Feb; 3(2):135-42. PubMed ID: 11812990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.